---
id: 244
title: Streptococcus pyogenes (Group A Strep)
category: organisms
subcategory: gram_positive_cocci
tags: [GAS, strep-throat, necrotizing-fasciitis, rheumatic-fever, penicillin, clindamycin]
difficulty: medium
---

## Question

What are key clinical syndromes and treatment considerations for *S. pyogenes* (GAS)? Use **"Penicillin First-Line, Add Clindamycin for Toxin (Necrotizing, TSS), Prevent Rheumatic Fever"** framework.

## Answer

### **Key Clinical Syndromes:**

**Pharyngitis ("Strep Throat"):**
- **Most common bacterial pharyngitis**
- **Sudden onset, fever, tonsillar exudates, tender cervical LN**
- **Treat to prevent rheumatic fever**

**Skin/Soft Tissue:**
- **Impetigo** (honey-crusted lesions)
- **Erysipelas** (superficial, well-demarcated, raised, bright red)
- **Cellulitis**
- **Necrotizing fasciitis** (life-threatening, rapid progression)
- **Myositis/myonecrosis**

**Scarlet Fever:**
- **Pharyngitis + sandpaper-like rash**
- **Strawberry tongue, circumoral pallor**
- **Erythrogenic toxin** (pyrogenic exotoxin)

**Invasive GAS (iGAS):**
- **Bacteremia, sepsis**
- **Streptococcal toxic shock syndrome (STSS)**
- **Necrotizing fasciitis**
- **Puerperal sepsis** (postpartum)

**Toxin-Mediated:**
- **Streptococcal toxic shock syndrome (STSS):**
  - Pyrogenic exotoxins (superantigens)
  - Hypotension, multiorgan failure, high mortality (30-50%)

**Post-Infectious Sequelae (Non-Suppurative):**
- **Acute rheumatic fever** (ARF) - 2-3 weeks post-pharyngitis
- **Post-streptococcal glomerulonephritis** (PSGN) - 1-3 weeks post-infection (pharyngitis or skin)

### **Treatment:**

**Pharyngitis:**
- **Penicillin VK 500mg PO BID-TID × 10 days** (first-line)
- **Amoxicillin 500mg PO BID × 10 days**
- **Benzathine penicillin G 1.2 million units IM × 1** (if adherence concern)
- **PCN allergy:**
  - Cephalexin 500mg PO BID × 10 days
  - Azithromycin 500mg daily × 5 days (resistance 5-10%)
  - Clindamycin 300mg PO TID × 10 days
- **Duration: 10 days** (prevent rheumatic fever)

**Erysipelas/Cellulitis:**
- **Penicillin VK 500mg PO QID** OR **amoxicillin 500mg PO TID × 5-10 days**
- **Severe:** Penicillin G 2-4 million units IV q4-6h OR ceftriaxone 1-2g IV daily

**Necrotizing Fasciitis/STSS:**
- **Penicillin G 4 million units IV q4h**
- **+ Clindamycin 900mg IV q8h** (ESSENTIAL - inhibits toxin production, effective in stationary phase)
- **+ IVIG 2 g/kg IV × 1** (if STSS with multiorgan failure)
- **Urgent surgical debridement** (life-saving, within 6-12h)

**Impetigo:**
- **Mupirocin 2% topical TID × 5 days** (localized)
- **Cephalexin 500mg PO QID × 7 days** (if extensive)

**Bacteremia/Invasive GAS:**
- **Penicillin G 4 million units IV q4h** + **clindamycin 900mg IV q8h × 10-14 days**

**Scarlet Fever:**
- **Same as pharyngitis** (penicillin VK × 10 days)

### **Why Clindamycin for Invasive/Toxin-Mediated?**

- **Inhibits toxin production** (pyrogenic exotoxins, M protein)
- **Effective in stationary phase** (β-lactams less effective when bacteria not actively dividing)
- **Decreases mortality** in necrotizing fasciitis, STSS

### **Post-Infectious Sequelae:**

**Acute Rheumatic Fever (ARF):**
- **Jones Criteria:** 2 major OR 1 major + 2 minor + evidence of GAS
- **Major:** Carditis, polyarthritis, chorea, erythema marginatum, subcutaneous nodules
- **Minor:** Fever, arthralgia, ↑ESR/CRP, prolonged PR interval
- **Prevention:** Treat GAS pharyngitis within 9 days (prevents ARF)
- **Secondary prophylaxis:** Benzathine PCG 1.2 million units IM monthly (if history of ARF, prevent recurrence)

**Post-Streptococcal Glomerulonephritis (PSGN):**
- **NOT prevented by antibiotics** (immune-mediated)
- **Hematuria, proteinuria, hypertension, edema**
- **Supportive care** (most resolve spontaneously)

### **Virulence Factors:**

**M Protein:**
- **Antiphagocytic** (evades immune clearance)
- **>200 serotypes** (type-specific immunity)
- **M1, M3, M12, M28** associated with invasive disease

**Pyrogenic Exotoxins (SPE-A, SPE-B, SPE-C):**
- **Superantigens** → massive cytokine release → STSS

**Streptolysin O (SLO):**
- **Lyses RBCs, neutrophils**
- **Anti-streptolysin O (ASO)** titer (evidence of recent infection)

**Streptokinase:**
- **Dissolves clots** (aids tissue invasion)

### **Special Considerations:**

**No Resistance to Penicillin:**
- ***S. pyogenes* NEVER develops resistance to penicillin** (unique among bacteria)
- **If treatment failure:** Non-compliance, reinfection, or non-GAS etiology

**Contact Prophylaxis:**
- **NOT routinely recommended** (unlike *N. meningitidis*)
- **Consider if:** Household contact with invasive GAS, immunocompromised

**Recurrent GAS Pharyngitis:**
- **Tonsillectomy** (if ≥7 episodes in 1 year, ≥5/year × 2 years, or ≥3/year × 3 years)

### **Complications:**

**Suppurative:**
- **Peritonsillar abscess**
- **Retropharyngeal abscess**
- **Cervical lymphadenitis**
- **Otitis media, sinusitis**

**Non-Suppurative (Immune-Mediated):**
- **Acute rheumatic fever** (prevented by treating pharyngitis)
- **Post-streptococcal glomerulonephritis** (NOT prevented by antibiotics)

## Key Points

### **Penicillin First-Line:**
- **Never develops resistance** to penicillin
- **Penicillin VK 500mg BID-TID × 10 days** (pharyngitis)

### **Add Clindamycin for Invasive/Toxin:**
- **Necrotizing fasciitis, STSS:** Penicillin G + **clindamycin** (inhibits toxin)

### **IVIG for STSS:**
- **2 g/kg IV × 1** (if multiorgan failure, hypotension)
- **Neutralizes superantigens**

### **Prevent Rheumatic Fever:**
- **Treat pharyngitis within 9 days** (prevents ARF)
- **10 days duration** (essential)

### **Necrotizing Fasciitis = Surgical Emergency:**
- **Urgent debridement** (within 6-12h) + penicillin + clindamycin

### **Clinical Pearls:**
- **Penicillin VK × 10 days** (pharyngitis, never resistant)
- **Necrotizing fasciitis:** Penicillin G + **clindamycin** (inhibits toxin) + urgent surgery
- **STSS:** Penicillin + clindamycin + **IVIG 2 g/kg**
- **Prevent rheumatic fever:** Treat within 9 days (10 days duration)
- **PSGN NOT prevented** by antibiotics (immune-mediated)
- **No PCN resistance** (unique)

## Sources

- [IDSA: Group A Streptococcal Pharyngitis Guidelines 2024]
- [IDSA: Skin and Soft Tissue Infection Guidelines 2024]

## Media

N/A
